TRUSELTIQ Trademark

Trademark Overview

On Monday, October 19, 2020, a trademark application was filed for TRUSELTIQ with the United States Patent and Trademark Office. The USPTO has given the TRUSELTIQ trademark a serial number of 90262906. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 25, 2022. This trademark is owned by QED Therapeutics, Inc.. The TRUSELTIQ trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Conducting research and development in the fields of cancer
truseltiq

General Information

Serial Number90262906
Word MarkTRUSELTIQ
Filing DateMonday, October 19, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 25, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 27, 2021

Trademark Statements

Goods and ServicesConducting research and development in the fields of cancer

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSunday, December 6, 2020
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameQED Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrisbane, CA 94005
Party NameQED Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBrisbane, CA 94005

Trademark Events

Event DateEvent Description
Monday, July 25, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, July 25, 2022ABANDONMENT - NO USE STATEMENT FILED
Wednesday, August 18, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 18, 2021CORRECTED NOA E-MAILED
Tuesday, August 17, 2021DIVISIONAL PROCESSING COMPLETE
Wednesday, July 21, 2021DIVISIONAL REQUEST RECEIVED
Tuesday, August 17, 2021SOU EXTENSION 1 GRANTED
Thursday, July 15, 2021SOU EXTENSION 1 FILED
Monday, August 2, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, July 15, 2021TEAS REQUEST TO DIVIDE RECEIVED
Thursday, July 15, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, June 23, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, June 23, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, June 23, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, June 23, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, June 23, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, June 22, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Saturday, May 29, 2021CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Saturday, May 29, 2021ASSIGNED TO PETITION STAFF
Tuesday, April 27, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 27, 2021PUBLISHED FOR OPPOSITION
Wednesday, April 7, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 6, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, April 6, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, April 6, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, March 25, 2021TEAS POST PUBLICATION AMENDMENT RECEIVED
Saturday, March 20, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, March 18, 2021ASSIGNED TO EXAMINER
Sunday, December 6, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, October 22, 2020NEW APPLICATION ENTERED

Related Keywords

truseltiq cancer fields development research conducting